Skip to content

Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application

A Study of Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application in Mild Cognitive Impairment and Mild Alzheimer's Dementia (Baseline Study)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02848404
Enrollment
20
Registered
2016-07-28
Start date
2016-06-30
Completion date
2017-02-28
Last updated
2020-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease, Mild Cognitive Impairment

Keywords

Mild cognitive impairment, Cognitive rehabilitation, Cognitive therapy, Alzheimer's disease, Memory enhancement, Categorical language fluency

Brief summary

The purpose of this study is to examine therapeutic efficacy of categorical language fluency smartphone game application in mild cognitive impairment and mild Alzheimer's dementia.

Detailed description

The Categorical Language Fluency Smartphone Game Application was developed based on the semantic distance training, which was effective in improving categorical language fluency of mild cognitive impairment and mild Alzheimer's dementia. 10 patients with mild cognitive impairment and another 10 patients with mild Alzheimer's dementia were recruited to examine therapeutic efficacy of the application.

Interventions

DEVICECategorical Language Fluency Smartphone Application

4 weeks' training

Sponsors

Seoul National University
CollaboratorOTHER
Ministry of Science and ICT, Republic of Korea
CollaboratorOTHER_GOV
Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged above 55 * Confirmed literacy * Diagnosed to mild cognitive impairment by International Working Group on Mild Cognitive Impairment and Clinical Dementia Rating(CDR) of 0 or 0.5. * Diagnosed to possible or probable Alzheimer's dementia by NINCDS-ADRDA and Clinical Dementia Rating(CDR) of 1 or below.

Exclusion criteria

* Evidence of delirium, confusion * Any neurological conditions causing cognitive decline such as Parkinson's disease, brain hemorrhage, brain tumor, normal pressure hydrocephalus * Evidence of severe cerebrovascular pathology * History of loss-of-consciousness over 1 hour due to head trauma or repetitive head trauma of mild severity * History of substance abuse or dependence such as alcohol * Presence of depressive symptoms that could influence cognitive function * Presence of medical comorbidities that could result in cognitive decline

Design outcomes

Primary

MeasureTime frameDescription
Application usage log4-weeks treatmentLog to assess compliance of participant(by describing frequency and duration of training by using application)

Secondary

MeasureTime frameDescription
Subjective Memory Complaint Questionnaireafter 4-weeks treatmentto evaluate efficacy of application
Geriatric Depression Scaleafter 4-weeks treatmentto evaluate efficacy of application
Korean version of MMSE for dementia screeningafter 4-weeks treatmentto evaluate efficacy of application

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026